Metronomic Oral Topotecan with Pazopanib Is an Active Antiangiogenic Regimen in Mouse Models of Aggressive Pediatric Solid Tumor

PURPOSE: Low dose metronomic (LDM) chemotherapy, combined with VEGF signaling pathway inhibitors, is a highly effective strategy to coordinately inhibit angiogenesis and tumor growth in many adult preclinical cancer models. We have tested the efficacies of daily oral LDM topotecan alone and in combi...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Kumar, Sushil, Mokhtari, Reza Bayat, Sheikh, Reihaneh, Wu, Bing, Zhang, Libo, Xu, Ping, Man, Shan, Oliveira, Indhira Dias, Yeger, Herman, Kerbel, Robert S., Baruchel, Sylvain
Médium: Artigo
Jazyk:Inglês
Vydáno: 2011
Témata:
Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC3687796/
https://ncbi.nlm.nih.gov/pubmed/21788355
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1078-0432.CCR-11-0078
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky